Session » SLE – Etiology & Pathogenesis Poster (1480–1506)
-
Abstract Number: 1480
LncRNA XIST Alters the Balance of Peripheral Blood Immune Cells in Systemic Lupus Erythematosus by Regulating the miR-17-92/OFLM4 and CEACAM8 Axis
-
Abstract Number: 1481
Malondialdehyde-acetaldehyde Antibodies Occur in Systemic Lupus Erythematosus and Associate Specifically with Neuropsychiatric Involvement
-
Abstract Number: 1482
LN Urinary Proteomics Reveals Common Biological Pathways Identified by Distinct Disease Measures
-
Abstract Number: 1483
Down-regulation of Hematopoietic Progenitor Kinase 1 by Aberrant Epigenetic Alterations in T Follicular Helper Cells Accounts for Excessive Immunity in Systemic Lupus Erythematosus
-
Abstract Number: 1484
B Cell Intracellular IFNβ as a Unique Cellular Marker for the Development of Lupus Nephritis
-
Abstract Number: 1485
Glycosphingolipids: Potential Urine Biomarkers of Therapeutic Response in Lupus Nephritis
-
Abstract Number: 1486
A Novel Requirement for IFNβ1 Signaling for IFNκ Induction in Keratinocytes
-
Abstract Number: 1487
Type I Interferon Modulates Langerhans Cell ADAM17 in Lupus to Contribute to Photosensitivity
-
Abstract Number: 1488
Metabolic Alterations of Systemic Lupus Erythematosus NK Cells Determine Response to Anti-CD38 and Anti-SLAMF7 Monoclonal Antibodies
-
Abstract Number: 1489
Identification of Mitochondrial Antigens Targeted by Autoantibodies in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1490
Myeloid and B Cell Transcriptional Phenotypes Reveal Race Dependent Differences in Early Autoimmunity
-
Abstract Number: 1492
A Permissive Factor of Anti-Ro+ Mothers of Neonatal Lupus Children Is Linked to Overt SLE Associated with Immunity to a Gut Commensal
-
Abstract Number: 1493
Association of the Soluble Terminal Complement Complex C5b-9 (sC5b-9) with Urinary Signs of Kidney Disease in a Swiss SLE Cohort
-
Abstract Number: 1494
Functional Effects of a Lupus-associated PRKG1 Variant on the RhoA-ROCK Pathway and Response to Type I Interferon
-
Abstract Number: 1495
Multiplexed Profiling of Treatment Naïve Cutaneous Lupus Skin Stratified by Patient Response to Antimalarials
-
Abstract Number: 1496
A Metagenome-wide Association Study Revealed Disease-specific Landscape of the Gut Microbiome of Systemic Lupus Erythematosus in Japanese
-
Abstract Number: 1497
Kidney Disease in Lupus Patients Is Linked to Monocytes’ Aberrant Spliceosome and Altered Expression of IFN-Response Related Genes
-
Abstract Number: 1498
Platelet Secreted LGALS3BP Induces a Pro-inflammatory Phenotype in Systemic Lupus Erythematosus
-
Abstract Number: 1499
Imbalance Between T Follicular Cells and T Regulatory Cells Involved in High Fat-Diet Associated Lupus Development in MRL/lpr Mice
-
Abstract Number: 1500
Expression of Neuropilin-1 Is Significantly Increased in Dendritic Cells and CD4 + T Cells and It Correlates Disease Activity in the Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1501
Molecular Modelling Predicts Inhibition of Functional Effects of Anti-thrombin III on Factor Xa Mediated Complement Activation by Anti- Factor Xa IgG in SLE and APS
-
Abstract Number: 1502
Longitudinal Changes in B Cell Subsets in Patients in the Mesenchymal Stromal Cell Trial in Lupus: Analysis of the First Cohort
-
Abstract Number: 1503
Putting the Pieces on the Board: Mapping SLE Nephritis Biopsies from the Accelerating Medicines Project Using High-Density Immunofluorescence Imaging
-
Abstract Number: 1504
Association Between Anti-RNP Antibodies and Interferon Gene Expression but Not Complement Consumption in SLE
-
Abstract Number: 1505
Inflammatory Dendritic Cell and Th17 Polarization in Mouse Model of Lupus Nephritis
-
Abstract Number: 1506
SLAMF6 Compartmentalization Regulates Autoimmune T Cell Responses